Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-09-11

FDA Approved: ZOLPIDEM TARTRATE SUBLINGUAL — Original Application (ENDO USA, Inc.)

View source ↗

Summary

FDA approved a generic zolpidem tartrate sublingual tablet under ANDA 204229 from ENDO USA, Inc. for the treatment of insomnia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Zolpidem Tartrate Sublingual (zolpidem tartrate sublingual)

Snippet

ORIG AP for ZOLPIDEM TARTRATE SUBLINGUAL (ZOLPIDEM TARTRATE SUBLINGUAL)